Nature's Miracle Reports 97.6% Revenue Decline and $5.9M Net Loss in Latest Quarter

Nature's Miracle Holding Inc. reported significant financial challenges in its latest 10-Q filing for the quarter ending September 30, 2025. The company generated revenues of $72,377, a stark decline of 97.6% compared to $3,052,727 in the same quarter of the previous year. This drop in revenue is attributed to cash constraints that limited inventory purchases, forcing the company to rely on existing stock. The average revenue per customer also fell sharply, from $51,741 in Q3 2024 to $3,016 in Q3 2025, reflecting a decrease in customer count from 59 to 24.

The company's cost of revenue mirrored the decline in sales, decreasing by 97.5% to $71,951 from $2,824,614 year-over-year. Consequently, gross profit was minimal at $426, down from $228,113, resulting in a gross margin of just 0.6%, compared to 7.5% in the prior year. Operating expenses also decreased by 40.1% to $1,331,949, primarily due to reduced stock compensation expenses and lower professional fees. However, the provision for credit losses surged by 246.5% to $126,824, indicating increased credit risk associated with outstanding receivables.

For the nine months ending September 30, 2025, Nature's Miracle reported a net loss of $5,961,537, a slight improvement from a loss of $6,825,461 in the same period of 2024. The company’s total assets increased to $22.1 million from $11.3 million at the end of 2024, largely due to the acquisition of Zak Properties, LLC, which was financed through the issuance of preferred stock and convertible notes. The company’s liabilities also rose, with total liabilities reaching $30.2 million, up from $25.7 million.

Operationally, Nature's Miracle has been focusing on expanding its product offerings and entering new markets. The company has made strategic moves, including the acquisition of Zak Properties for $17.5 million, which is expected to provide a steadier cash flow through rental income. Additionally, the company is exploring joint ventures in vertical farming and has entered into a licensing agreement with Datavault AI for tokenization technology. Despite these efforts, the company faces substantial liquidity challenges, with a working capital deficit of approximately $19 million as of September 30, 2025.

Looking ahead, Nature's Miracle is actively seeking additional financing to replenish inventory and support its operations. The company has access to a $20 million equity financing program and has received investments from related parties. However, management has expressed concerns about the company's ability to continue as a going concern if it cannot secure the necessary funding. The outlook remains uncertain as the company navigates its financial difficulties while attempting to stabilize and grow its operations in the agriculture technology sector.